MTOR and acute myeloid leukemia: We performed a proteomic comparison of AML cells that showed general increases in PI3K-Akt-mTOR activation in response to insulin (Fig. 1, subcluster I, seven patients) and those that showed diverse responses (subclusters II–IV, seven patients with decreased phosphorylation for at least one mediator in response to insulin).